Navigation Links
American Oriental Bioengineering Introduces Wujia Rongxue Oral Liquid
Date:11/11/2010

NEW YORK, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving healthcare through the development, manufacture and commercialization of a broad range of prescription and over-the-counter ("OTC") products, today announced the commercial launch of AOBO Wujia Rongxue Oral Liquid, ("AWRO Liquid"), an OTC herbal supplement aimed at boosting energy and health, especially for middle aged and elderly individuals, by strengthening their kidney function, which is believed to play a critical role in health according to the doctrines of traditional Chinese medicine.  

Mr. Tony Liu, Chairman and CEO of AOBO, commented, "As the disposable income increases in China, the demand for health supplements has also risen rapidly.  In China, individuals not only purchase these supplements for themselves but also as gifts for others.  In fact, gift purchases contribute significantly to the strong performance of the health supplements market. Although not so popular in the USA, this gift purchase behavior pattern in the health supplement market is common place in China. We believe the addition of AWRO Liquid will complement our existing product offerings as well as contribute to the growth momentum of our future OTC product sales."

About American Oriental Bioengineering, Inc.American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over-the-counter products.  

Forward-Looking StatementsStatements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995.  Such statements involve risks and uncertainties that may cause act
'/>"/>

SOURCE American Oriental Bioengineering, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Analyses of Data From RE-LY Trial, Involving Oral Anticoagulant Pradaxa, to be Presented at American Heart Associations Scientific Sessions
2. Thoratec Announces Webcast of Investor Presentation at American Heart Association Meeting
3. Philips Announces Its Portfolio of Lifesaving Solutions Supports New American Heart Association 2010 CPR and ECC Guidelines
4. Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology
5. Telik Announces Presentation at American Society of Hematology Annual Meeting
6. American Council on Exercise (ACE) Announces Nationwide Effort to Eliminate Obesity in America
7. ChemoCentryx Reports Positive Phase I Results for CCX168, a Novel C5aR Antagonist, at the Annual American College of Rheumatology Meeting (ACR)
8. HeartWare Bridge-to-Transplant Data Featured as Late Breaking Clinical Trial at American Heart Association Scientific Sessions 2010
9. Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting
10. American Regent Initiates Voluntary Recall of Magnesium Sulfate Injection, USP 50% (25 grams/50 mL), 50mL Single Dose Vial Lot # 0491
11. Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... LAS VEGAS , July 30, 2014  DigiPath, ... provider that is expanding into the cannabis testing and ... development in its business and affairs not previously disclosed ... for the recent unusual market action. "We ... securities over the last three trading days," said ...
(Date:7/30/2014)... /PRNewswire-iReach/ -- This is a professional and in-depth ... (CAS 9041-08-1) & calcium (CAS 37270-89-6) industry. The ... sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) including ... then explores global and China,s top manufacturers of ... listing their product specification, capacity, production value, cost, ...
(Date:7/30/2014)... VILLAGE, Nev. , July 30, 2014  PDL ... announced that company management will participate in the Jefferies ... Boston , Massachusetts. The conference will occur on August ... About PDL BioPharma, Inc. PDL BioPharma manages ... of its Queen et al. antibody humanization patents and ...
Breaking Medicine Technology:DigiPath No New Corporate Developments 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit 2
... Oct. 26, 2011 Reportlinker.com ... research report is available in ... Early Stage Drug Safety Strategies ... towards achieving clinical success ...
... Oct. 26, 2011 Reportlinker.com announces ... is available in its catalogue: ... Pharmaceutical R&D: Company strategies, emerging markets ... http://www.reportlinker.com/p0114851/Key-Trends-in-Offshoring-Pharmaceutical-RD-Company-strategies-emerging-markets-and-impact-on-ROI.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development ...
Cached Medicine Technology:Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 2Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 3Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 4Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 5Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 6Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 7Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success 8Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI 2Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI 3Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI 4Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI 5Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI 6Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI 7Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI 8Key Trends in Offshoring Pharmaceutical R&D: Company Strategies, Emerging Markets and Impact on ROI 9
(Date:7/30/2014)... WEDNESDAY, July 30, 2014 (HealthDay News) -- It can happen ... television, dresser or computer monitor and gets critically injured ... of a young child should look around their homes and ... a child. Imagining it is better than it becoming a ... Emergency Physicians, said in a college news release. Between ...
(Date:7/30/2014)... to fuel cancer as well as evolutionary changes in ... that occur randomly throughout the genome. , However, recent ... formation of multiple mutations that arise simultaneously and in ... mutations are frequently found in regions where chromosomal rearrangements ... Cell Reports , may one day lead to ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Visitors to ... contributed over $8,500 to ensure its protection. Bob Kiesendahl, ... a check to the Delaware Highlands Conservancy for donations ... The small $2-per-stay donations add up fast, as visitors ... the Upper Delaware River Region. , The Kiesendahl family ...
(Date:7/30/2014)... 2014) The phrase "we caught it early" is possibly ... midst of a cancer diagnosis. Combating cancer in its ... certain part of the body, gives patients the best ... colon, prostate and other forms of cancer are touted ... providers recommend cancer screenings as a precautionary measure, especially ...
(Date:7/30/2014)... ... ... ... , UCLA ... For the study, published this week in the peer-reviewed journal Quality of Life Research , a UCLA team led by Dr. ...
Breaking Medicine News(10 mins):Health News:Tip-Over Furniture Can Kill Kids 2Health News:Biologists describe mechanism promoting multiple DNA mutations 2Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 3Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 3
... A University of Melbourne study has revealed that certain ... link between mammographic breast density and breast cancer. ... Health says women vary greatly in their underlying risk ... possible new pathways into the development of breast cancer." ...
... Del.Feb. 16, 2010 Cancer , the peer-reviewed international ... a study conducted by HealthCore, Inc. in its ... treatment between commercially insured African-American and white women. ... of previous studies conducted in populations using ...
... team of researchers has found that adding a humanized monoclonal ... new or enlarged brain lesions in patients with relapsing multiple ... and in the March edition of the Lancet Neurology ... which the body,s immune system attacks the fatty substance that ...
... Celebrity ... will be awarded $5,000 for best eye care tips., , ... Atlanta, GA (Vocus) February 16, 2010 -- Just as people ... the AIR OPTIX AQUA brand team is partnering with Carmindy, makeup artist on TLC’s hit ...
... with the worst cases report the fewest nightmares, study finds ... that accompany severe sleep apnea may be counterbalanced by this ... , "We found that people with significant sleep apnea have ... fewer nightmares," said Dr. Jim Pagel, lead author of a ...
... ... the use of social tools. , ... Minneapolis, MN (PRWEB) February 16, 2010 -- BusinessCard2 ™, a ... of the Social Business Innovation Awards. The competition was established to recognize great ...
Cached Medicine News:Health News:Study reveals genetic link between mammographic density and breast cancer 2Health News:Cancer publishes study confirming disparity in breast cancer treatment 2Health News:Promising therapy for relapsing multibple sclerosis 2Health News:Promising therapy for relapsing multibple sclerosis 3Health News:CIBA VISION Partners with TLC's Carmindy to Educate Consumers About Healthy Eye Habits 2Health News:CIBA VISION Partners with TLC's Carmindy to Educate Consumers About Healthy Eye Habits 3Health News:CIBA VISION Partners with TLC's Carmindy to Educate Consumers About Healthy Eye Habits 4Health News:Severe Sleep Apnea Has Silver Lining 2Health News:Severe Sleep Apnea Has Silver Lining 3Health News:BusinessCard2 Wins Social Business Innovation Award 2Health News:BusinessCard2 Wins Social Business Innovation Award 3
Lyphochek Coagulation Control is a human plasma control for monitoring the performance of routine coagulation tests. It has an extended reconstituted stability which helps reduce waste and save money...
Lyphochek® Hemoglobin A1C Linearity Set is a human whole blood based product designed to verify linearity throughout the patient reportable range of hemoglobin A1C assays....
... Hematology-16 Control is specifically ... most hematology analyzers that ... parameters and 3-part white ... trilevel control can be ...
Each Liquichek Seroconversion Panel features a series of serum specimens drawn over time from one individual to show the progression from a negative to a positive disease state....
Medicine Products: